Lifelong prevention of atherosclerotic cardiovascular disease (ASCVD) through LDL-C control - Means and cost/benefit of sustained very low lifetime LDL-C targets

被引：1
|
作者：
Dalakoti, Mayank [1 ,2 ,3 ]
Virani, Salim [4 ,5 ,6 ]
机构：
[1] Natl Univ Heart Ctr, Dept Cardiol, Singapore, Singapore
[2] Ng Teng Fong Gen Hosp, Dept Med, Singapore, Singapore
[3] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England
[4] Aga Khan Univ, Dept Med, Karachi, Pakistan
[5] Texas Heart Inst, Houston, TX USA
[6] Baylor Coll Med, Sect Cardiovasc Res, Houston, TX USA
来源：
AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY | 2024年 / 19卷
关键词：
Keywords; LDL-C; Primary prevention; Primordial prevention; Preventive cardiology; Lipids; CHOLESTEROL; MANAGEMENT;
D O I：
10.1016/j.ajpc.2024.100720
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Real-World Risk of Recurrent Cardiovascular Events in Atherosclerotic Cardiovascular Disease Patients with LDL-C Above Guideline-Recommended Threshold: A Retrospective Observational Study
    Mackinnon, Erin S.
    Leiter, Lawrence A.
    Wani, Rajvi J.
    Burke, Natasha
    Shaw, Eileen
    Witges, Kelcie
    Goodman, Shaun G.
    CARDIOLOGY AND THERAPY, 2024, 13 (01) : 205 - 220
  • [22] Knowledge of HbA1c and LDL-C treatment goals, subjective level of disease-related information and information needs in patients with atherosclerotic cardiovascular disease
    Brockmeyer, Maximilian
    Wies, Emilia
    Joerges, Jamuna
    Sommer, Jana
    Borgmann, Sandra Olivia
    Chernyak, Nadja
    Lin, Yingfeng
    Parco, Claudio
    Schulze, Volker
    Heinen, Yvonne
    Kelm, Malte
    Icks, Andrea
    Perings, Stefan
    Wolff, Georg
    CLINICAL CARDIOLOGY, 2023, 46 (02) : 223 - 231
  • [23] Lipid-lowering therapy and LDL-C control for primary prevention in persons with diabetes across 90 health systems in the United States
    Decicco, Emily
    Peterson, Eric D.
    Gupta, Anand
    Gillard, Kristin Khalaf
    Sarnes, Evelyn
    Navar, Ann Marie
    AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2023, 16
  • [24] Safety and Tolerability of Very Low LDL-C Levels in Patients Treated with 52 Weeks of Evolocumab (AMG 145)
    Koren, Michael J.
    Blom, Dirk
    Giugliano, Robert P.
    Stroes, Erik
    Somaratne, Ransi
    Lowy, Andrew
    Monsalvo, Maria L.
    Hsu, Hui-Chun
    Wasserman, Scott M.
    Scott, Rob
    Sabatine, M. S.
    CIRCULATION, 2014, 130
  • [25] Characterization and LDL-C management in a cohort of high and very high cardiovascular risk patients: The PORTRAIT-DYS study
    Gavina, Cristina
    Seabra-Carvalho, Daniel
    Aguiar, Carlos
    Anastassopoulou, Anastassia
    Teixeira, Carla
    Ruivo, Jorge A.
    Almeida, Elia
    Luz-Duarte, Leonor
    Corte-Real, Ana
    Canelas-Pais, Mariana
    Taveira-Gomes, Tiago
    CLINICAL CARDIOLOGY, 2024, 47 (01)
  • [26] A LASSO-derived model for the prediction of nonattainment of target LDL-C reduction with PCSK9 inhibitors in patients with atherosclerotic cardiovascular disease
    Duan, Xiaochun
    Zhang, Mengdi
    Sun, Xiaodong
    Lin, Yang
    Peng, Wenxing
    LIPIDS IN HEALTH AND DISEASE, 2025, 24 (01)
  • [27] Factors Associated With Achievement of Blood Pressure, Low-Density Lipoprotein Cholesterol (LDL-C), and Glycemic Targets for Primary Prevention of Cardiovascular Diseases Among High Cardiovascular Risk Malaysians in Primary Care
    Baharudin, Noorhida
    Ramli, Anis Safura
    Ramland, Siti Syazwani
    Badlie-Hisham, Nurul Izzaty
    Mohamed-Yassin, Mohamed-Syarif
    JOURNAL OF PRIMARY CARE AND COMMUNITY HEALTH, 2023, 14
  • [28] Ezetimibe Use and LDL-C Goal Achievement: A Retrospective Database Analysis of Patients with Clinical Atherosclerotic Cardiovascular Disease or Probable Heterozygous Familial Hypercholesterolemia
    Menzin, Joseph
    Aggarwal, Jyoti
    Boatman, Brian
    Yu, Jeffrey
    Stern, Kevin
    Harrison, David J.
    Patel, Jeetvan G.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2017, 23 (12): : 1270 - +
  • [29] Case report: Coronary atherosclerosis in a patient with long-standing very low LDL-C without lipid-lowering therapy
    Mottola, Giorgio
    Welty, Francine K.
    Mojibian, Hamid R.
    Faridi, Kamil F.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [30] In pediatric familial hypercholesterolemia, lipoprotein(a) is more predictive than LDL-C for early onset of cardiovascular disease in family members
    Zawacki, Amy W.
    Dodge, Ann
    Woo, Kaitlin M.
    Ralphe, J. Carter
    Peterson, Amy L.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2018, 12 (06) : 1445 - 1451
12345